Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Comparative Neurology
|
July 15, 2018
Target-specific forebrain projections and appropriate synaptic inputs of hESC-derived dopamine neurons grafted to the midbrain of parkinsonian rats
Tiago Cardoso, Andrew F Adler, Bengt Mattsson, et al.
Cell Reports
|
September 26, 2019
hESC-Derived Dopaminergic Transplants Integrate into Basal Ganglia Circuitry in a Preclinical Model of Parkinson's Disease
Andrew F Adler, Tiago Cardoso, Sara Nolbrant, et al.
Cell Reports
|
January 5, 2017
TRIM28 Controls a Gene Regulatory Network Based on Endogenous Retroviruses in Human Neural Progenitor Cells
Per Ludvik Brattås, Marie E Jönsson, Liana Fasching, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 17, 2020
Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD
Deirdre B Hoban, Shelby Shrigley, Bengt Mattsson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 14, 2024
TARGET-seq: Linking single-cell transcriptomics of human dopaminergic neurons with their target specificity
Alessandro Fiorenzano, Petter Storm, Edoardo Sozzi, et al.
The Journal of Clinical Investigation
|
July 4, 2012
Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment
Yosif M Ganat, Elizabeth L Calder, Sonja Kriks, et al.
Development (Cambridge, England)
|
October 28, 2022
Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain
Marcella Birtele, Petter Storm, Yogita Sharma, et al.
BMJ Open
|
December 30, 2025
STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson's disease
Gesine Paul, Hjalmar Bjartmarz, Anders Björklund, et al.
Cell Stem Cell
|
October 6, 2023
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
Agnete Kirkeby, Jenny Nelander, Deirdre B Hoban, et al.
Nature Biotechnology
|
May 2, 2025
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease
Roger A Barker, Nicholas P Lao-Kaim, Natalie Valle Guzman, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Comparative Neurology
|
July 15, 2018
Target-specific forebrain projections and appropriate synaptic inputs of hESC-derived dopamine neurons grafted to the midbrain of parkinsonian rats
Tiago Cardoso, Andrew F Adler, Bengt Mattsson, et al.
Cell Reports
|
September 26, 2019
hESC-Derived Dopaminergic Transplants Integrate into Basal Ganglia Circuitry in a Preclinical Model of Parkinson's Disease
Andrew F Adler, Tiago Cardoso, Sara Nolbrant, et al.
Cell Reports
|
January 5, 2017
TRIM28 Controls a Gene Regulatory Network Based on Endogenous Retroviruses in Human Neural Progenitor Cells
Per Ludvik Brattås, Marie E Jönsson, Liana Fasching, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 17, 2020
Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD
Deirdre B Hoban, Shelby Shrigley, Bengt Mattsson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 14, 2024
TARGET-seq: Linking single-cell transcriptomics of human dopaminergic neurons with their target specificity
Alessandro Fiorenzano, Petter Storm, Edoardo Sozzi, et al.
The Journal of Clinical Investigation
|
July 4, 2012
Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment
Yosif M Ganat, Elizabeth L Calder, Sonja Kriks, et al.
Development (Cambridge, England)
|
October 28, 2022
Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain
Marcella Birtele, Petter Storm, Yogita Sharma, et al.
BMJ Open
|
December 30, 2025
STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson's disease
Gesine Paul, Hjalmar Bjartmarz, Anders Björklund, et al.
Cell Stem Cell
|
October 6, 2023
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
Agnete Kirkeby, Jenny Nelander, Deirdre B Hoban, et al.
Nature Biotechnology
|
May 2, 2025
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease
Roger A Barker, Nicholas P Lao-Kaim, Natalie Valle Guzman, et al.
Page
of 2